Herbas VPB

Print
EN | LT
LT - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
EN - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C12Q 1/68
C07H 21/04
European patent
(11) Number of the document 2439284
(13) Kind of document T
(96) European patent application number 11178194.4
Date of filing the European patent application 2005-03-31
(97) Date of publication of the European application 2012-04-11
(45) Date of publication and mention of the grant of the patent 2019-05-08
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
558218 P 2004-03-31 US
561095 P 2004-04-09 US
565753 P 2004-04-27 US
565985 P 2004-04-27 US
574035 P 2004-05-25 US
577916 P 2004-06-07 US
592287 P 2004-07-29 US
Inventors
(72)
Bell, Daphne Winifred, US
Haber, Daniel A., US
Janne, Pasi Antero, US
Johnson, Bruce E., US
Lynch, Thomas J., US
Meyerson, Matthew, US
Paez, Juan Guillermo, US
Sellers, William R., US
Settleman, Jeffrey E., US
Sordella, Raffaella, US
Grantee
(73) Dana-Farber Cancer Institute, Inc., 450 Brookline Avenue, Boston, MA 02215, US
The General Hospital Corporation, 55 Fruit Street, Boston, MA 02114, US
Title
(54) Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
  Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
Last update date 2021-04-30